Stroke in a young boy with β-thalassemia intermedia secondary to moyamoya syndrome

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 7, 2010, Pages 568-570

  Oberoi, Sapna ^a   Bansal, Deepak ^a   Singh, Paramjeet ^b   Marwaha, Ram K ^a  

^a Advanced Pediatrics Centre   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Hemiparesis; Hemoglobinopathy; Moyamoya disease; MRI; Proyhrombotic state; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; FOLIC ACID; HEMOGLOBIN; HEMOGLOBIN A2; HEMOGLOBIN F; HYDROXYUREA;

ANTERIOR CEREBRAL ARTERY; ARTICLE; BETA THALASSEMIA; BODY HEIGHT; BODY WEIGHT; CASE REPORT; CHILD; DRUG WITHDRAWAL; EMERGENCY WARD; ERYTHROCYTE TRANSFUSION; EXERCISE TOLERANCE; FACIAL NERVE PARALYSIS; GENE DELETION; GRAY MATTER; HEMIPARESIS; HEMISPHERE; HEMOGLOBIN DETERMINATION; HEPATOSPLENOMEGALY; HUMAN; LIVER FUNCTION TEST; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE CEREBRAL ARTERY; MOYAMOYA DISEASE; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLOR; PHYSIOTHERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; STROKE; WHITE MATTER; BRAIN ANGIOGRAPHY; PATHOLOGY;

BETA-THALASSEMIA; CEREBRAL ANGIOGRAPHY; CHILD, PRESCHOOL; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MOYAMOYA DISEASE; STROKE;

EID: 77958158877     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181ed0e84     Document Type: Article

References (21)

1. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ("moyamoya" disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997;99: S238-S240.
2. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288-294.
3. Merkel KH, Ginsberg PL, Parker JC Jr, et al. Cerebrovascular disease in sickle cell anemia: a clinical, pathological and radiological correlation. Stroke. 1978;9:45-52.
4. Eldor A, Durst R, Hy-Am E, et al. A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. Br J Haematol. 1999;107: 739-746.
5. Mukherjee A. Moyamoya disease and b-thalassemia. J Assoc Physicians India. 1995;43:710-711.
6. Sanefuji M, Ohga S, Kira R, et al. Moyamoya syndrome in a splenectomized patient with beta-thalassemia intermedia. J Child Neurol. 2006;21:75-77.
7. Parker TM, Ward LM, Johnston DL, et al. A case of moyamoya syndrome and hemoglobin E/Beta-thalassemia. Pediatr Blood Cancer. 2009;52:422-424.
8. Göksel BK, Ozdogu H, Yildirim T, et al. Beta-thalassemia intermedia associated with moyamoya syndrome. J Clin Neurosci. 2010;17:919-920.
9. Takagi Y, Kikuta K, Nozaki K, et al. Histological features of middle cerebral arteries from patients treated for Moyamoya disease. Neurol Med Chir (Tokyo). 2007;47:1-4.
10. Fukui M, Kono S, Sueishi K, et al. Moyamoya disease. Neuropathology. 2000;20:S61-S64.
11. Tokunaga Y, Ohga S, Suita S, et al. Moyamoya syndrome with spherocytosis: effect of splenectomy on strokes. Pediatr Neurol. 2001;25:75-77.
12. Lin HC, Chen RL, Wang PG. Paroxysmal nocturnal hemoglobinuria presenting as moyamoya syndrome. Brain Dev. 1996;18:157-159.
13. Cohen N, Berant M, Simon J. Moyamoya and Fanconis anemia. Pediatrics. 1980;65:804-805.
14. Stockman JA, Nigro MA, Mishkin MM, et al. Occlusion of large cerebral vessels in sickle-cell anemia. N Engl J Med. 1972;287:846-849.
15. Setty BN, Stuart MJ, Dampier C, et al. Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet 2003;362:1450-1455.
16. Cappellini MD, Robbiolo L, Bottasso BM, et al. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol. 2000; 111:467-473.
17. Taher A, Ismaeel H, Mehio G, et al. Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost. 2006;96:488-491.
18. Tripatara A, Jetsrisuparb A, Teeratakulpisarn J, et al. Hemostatic alterations in splenectomized and non-splenectomized patients with beta-thalassemia/hemoglobin E disease. Thromb Res. 2007;120:805-810.
19. Sharma S, Raina V, Chandra J, et al. Lupus anticoagulant and anticardiolipin antibodies in polytransfused beta thalassemia major. Hematology. 2006;11:287-290.
20. Kashef S, Karimi M, Amirghofran Z, et al. Antiphospholipid antibodies and hepatitis C virus infection in Iranian thalassemia major patients. Int J Lab Hematol. 2008;30:11-16.
21. Houkin K, Kuroda S, Nakayama N. Cerebral revascularization for moyamoya disease in children. Neurosurg Clin N Am. 2001;12:575-584.